We are live on ! Find out more
PHGE icon

BiomX
PHGE

17 hedge funds and large institutions have $21.3M invested in BiomX in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

31% more funds holding

Funds holding: 13 → 17 (+4)

0% less ownership

Funds ownership: 0.13% → 0.13% (-0%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

28% less capital invested

Capital invested by funds: $29.5M → $21.3M (-$8.18M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
3
Reduced
4
Closed
1
Calls
$47K
Puts
–
Net Calls
+$47K
Net Calls Change
-$45K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$2.04M
2
KC
Kepos Capital
New York
+$1.84M
3
BCM
Bridgeway Capital Management
Texas
+$394K
4
Jane Street
Jane Street
New York
+$179K
5
Renaissance Technologies
Renaissance Technologies
New York
+$170K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$543K
2
Millennium Management
Millennium Management
New York
-$540K
3
UBS Group
UBS Group
Switzerland
-$55K
4
TWMP
Taylor Wealth Management Partners
Massachusetts
-$25.6K
5
SCM
Silverarc Capital Management
Massachusetts
-$78
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$8.61M +$2.04M +2,632 +22%
JJ
2
Johnson & Johnson
New Jersey
$6.53M +$8.7M +11,228 New
MI
3
MMCAP International
Cayman Islands
$2.09M – – –
KC
4
Kepos Capital
New York
$1.38M +$1.84M +2,372 New
Millennium Management
5
Millennium Management
New York
$903K -$540K -697 -31%
RA
6
Royce & Associates
New York
$691K -$543K -701 -37%
BCM
7
Bridgeway Capital Management
Texas
$614K +$394K +509 +93%
Jane Street
8
Jane Street
New York
$134K +$179K +231 New
Renaissance Technologies
9
Renaissance Technologies
New York
$128K +$170K +220 New
TWMP
10
Taylor Wealth Management Partners
Massachusetts
$78K -$25.6K -33 -20%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$42K +$56.6K +73 New
Bank of America
12
Bank of America
North Carolina
$36K +$48K +62 New
BlackRock
13
BlackRock
New York
$18K – – –
Morgan Stanley
14
Morgan Stanley
New York
$6K – – –
RE
15
RBC Europe
United Kingdom
$5.51K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$4K +$1.55K +2 +33%
UBS Group
17
UBS Group
Switzerland
$2K -$55K -71 -96%
SCM
18
Silverarc Capital Management
Massachusetts
– -$78 -75 Closed

PHGE Hedge Fund Activity: Q3 2021 in Review

17 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q3 2021, worth a combined $21.3M — down 28% from $29.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PHGE positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was OrbiMed, adding an estimated $2.04M. The largest seller was Royce & Associates, cutting an estimated $543K.

  • 17 institutional investors held BiomX (PHGE) as of Q3 2021, up from 13 in Q2 2021.
  • Funds reported $21.3M of BiomX stock for Q3 2021, down 28% quarter-over-quarter.
  • 6 funds opened new BiomX positions in Q3 2021 and 1 closed out, a net change of +5 holders.
  • The largest BiomX buyer in Q3 2021 was OrbiMed, an estimated $2.04M added.
  • The largest BiomX seller in Q3 2021 was Royce & Associates, an estimated $543K sold.

Based on aggregated 13F filings for Q3 2021.